Recall Register

Food, drugs, devices › Firms

PACIRA PHARMACEUTICALS INC

FDA recalling firm · 4 enforcement events · 4 product records · 2012–2024 · CA

PACIRA PHARMACEUTICALS INC has 4 FDA enforcement events on this register (4 product records) between 2012 and 2024: 4 drug; the busiest year was 2024 with 2.

0% of its events are Class I; the most common class is Class II (4). 2 events are listed as ongoing; the recalling firm's address is in CA.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

InitiatedProduct (first record)TypeClassRecordsStatus
12 Jun 2024Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC…DrugClass II1Ongoing
7 May 2024Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC…DrugClass II1Ongoing
21 Nov 2019EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,DrugClass II1Terminated
17 Dec 2012EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USADrugClass II1Terminated

By type and class

Drug4
Class II4

Class I: 0% of this firm's events; 18% of all events on the register.

Events by year

12
14
16
18
20
22
24
26
Enforcement events for PACIRA PHARMACEUTICALS INC by year initiated.

Questions and answers

How many FDA recalls has PACIRA PHARMACEUTICALS INC had?

4 enforcement events (4 product records) on this register, 2012–2024: 4 drug.

Are any PACIRA PHARMACEUTICALS INC recalls ongoing?

2 events are listed as ongoing in the current openFDA export.

What class are PACIRA PHARMACEUTICALS INC recalls?

4 Class II. 0% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.